| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DUOL | Class A Common Stock | Options Exercise | $202K | +14K | +15.14% | $14.42 | 106K | Aug 21, 2024 | Direct | |
| transaction | DUOL | Class A Common Stock | Sale | -$267K | -1.31K | -1.23% | $203.76 | 105K | Aug 21, 2024 | Direct | F1, F2 |
| transaction | DUOL | Class A Common Stock | Sale | -$321K | -1.57K | -1.49% | $204.60 | 104K | Aug 21, 2024 | Direct | F1, F3 |
| transaction | DUOL | Class A Common Stock | Sale | -$405K | -1.97K | -1.9% | $205.73 | 102K | Aug 21, 2024 | Direct | F1, F4 |
| transaction | DUOL | Class A Common Stock | Sale | -$956K | -4.62K | -4.55% | $207.02 | 97K | Aug 21, 2024 | Direct | F1, F5 |
| transaction | DUOL | Class A Common Stock | Sale | -$643K | -3.1K | -3.19% | $207.75 | 93.9K | Aug 21, 2024 | Direct | F1, F6 |
| transaction | DUOL | Class A Common Stock | Sale | -$349K | -1.67K | -1.78% | $209.07 | 92.2K | Aug 21, 2024 | Direct | F1, F7 |
| transaction | DUOL | Class A Common Stock | Sale | -$705K | -3.36K | -3.64% | $209.80 | 88.9K | Aug 21, 2024 | Direct | F1, F8 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DUOL | Stock Option (Right to Buy) | Options Exercise | $0 | -14K | -19.88% | $0.00 | 56.4K | Aug 21, 2024 | Class A Common Stock | 14K | $14.42 | Direct | F9 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan adopted on May 22, 2024. |
| F2 | The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $203.22 to $204.21, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| F3 | The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $204.22 to $205.20, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| F4 | The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $205.31 to $206.24, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| F5 | The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $206.41 to $207.40, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| F6 | The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $207.41 to $208.36, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| F7 | The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $208.44 to $209.42, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| F8 | The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $209.45 to $210.18, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| F9 | The shares subject to the option are fully vested and exercisable. |